-

Cedar Gate Technologies Named Innovation Leader in the U.S. Population Health Management Market

From a field of 50 technology vendors, Cedar Gate ranked highest on the Frost Radar™ Innovation Index.

GREENWICH, Conn.--(BUSINESS WIRE)--Cedar Gate Technologies (Cedar Gate), a leading value-based care technology and services company, was named innovation leader in the Frost Radar™, U.S. Population Health Management, 2024 report.

The Frost Radar™ report benchmarks technology vendors in the U.S. population health management market based on innovation and growth criteria. With over 50 companies included in the study, “Cedar Gate Technologies scored highest on the innovation index with its composable, flexible, robust, and configurable platform and targeted efforts on AI/ML and generative AI capabilities for PHM,” according to the report.

“Cedar Gate’s robust and composable PHM portfolio empowers value-based care use cases at critical interaction points between payers and providers. This effectively links information, insights and action with innovative data, analytics, and care technologies that support a collaborative approach to population health,” said Sagar Mukhekar, Industry Analyst at Frost & Sullivan.

“Our focus is building technology that empowers payers, providers, and self-funded employers to maximize their performance in value-based care programs,” said David B. Snow, Jr., Chairman and CEO of Cedar Gate Technologies. “To have our data, analytics, and care technologies recognized for innovation leadership is valuable external validation of our commitment to supporting the evolving needs of our clients and the markets they serve.”

The report examined Cedar Gate’s population health management capabilities, which include capabilities from its Analytics and Care product lines:

  • Value-Based Care Analytics
  • Healthcare Benefits Analytics
  • Care Management
  • Clinical Decision Support
  • Utilization Management

The full report is available for download here.

About Cedar Gate Technologies

Cedar Gate enables payers, providers, employers, and service administrators to excel at value-based care with a unified technology and services platform delivering analytics, population health, and payment technology on a single data management foundation. From primary care attribution, to bundled payments, to capitation, Cedar Gate is improving clinical, financial, and operational outcomes for every payment model in all lines of business.

About Frost & Sullivan

For over six decades, Frost & Sullivan has helped build sustainable growth strategies for Fortune 1000 companies, governments, and investors. We apply actionable insights to navigate economic changes, identify disruptive technologies, and formulate new business models to create a stream of innovative growth opportunities that drive future success. Contact us: Start the discussion.

Contacts

Gina Ford, Chief Marketing Officer
gina.ford@cedargate.com

Cedar Gate Technologies


Release Versions

Contacts

Gina Ford, Chief Marketing Officer
gina.ford@cedargate.com

More News From Cedar Gate Technologies

Cedar Gate’s “Bundles Bootcamp” Offers Education, Insights into Complex VBC Payment Model

GREENWICH, Conn.--(BUSINESS WIRE)--Cedar Gate Technologies (Cedar Gate) recently launched “Bundles Bootcamp,” a free educational series for healthcare professionals participating in or interested in bundled payment models. The series takes a deep dive into bundled payments, an advanced alternative payment model gaining traction in the U.S. to help reduce healthcare costs and improve quality. Bundles Bootcamp is free and includes six modules covering: History of Bundled Payments Retrospective vs...

New Data Finds 31% of Working Americans and Their Families have a Cardiac Disorder

GREENWICH, Conn.--(BUSINESS WIRE)--Cedar Gate Technologies (Cedar Gate), a leading value-based care technology and services company, today released a critical analysis of heart health trends across the U.S., revealing that 31% of the workforce and their families suffer from a cardiac disorder or hypertension, a significant risk factor for such disorders. This data, derived from Cedar Gate’s National Healthcare Benchmark Database, analyzed claims data from July 2022 through June 2023 and represe...

Despite Risks and High Costs, Analysis Finds Only 35% of COPD and Asthma Patients Get Flu Vaccines

GREENWICH, Conn.--(BUSINESS WIRE)--An analysis from Cedar Gate Technologies (Cedar Gate) reveals that only 34.7% of commercially insured patients diagnosed with chronic obstructive pulmonary disease (COPD) or asthma are receiving their annual flu shots, leaving them vulnerable to severe complications and higher treatment costs. Data from the 2022-2023 flu season shows that, despite the well-known risks, these high-risk patients skip vaccination at alarming rates, which can result in more emerge...
Back to Newsroom